1. Acknowledgement

   Acknowledgments 26 December 2012 Pages: 2313 - 2317

2. Can a New Ultra-Long-Acting Insulin Analogue Improve Patient Care? Investigating the Potential Role of Insulin Degludec

   • Jennifer D. Robinson
   • Joshua J. Neumiller
   • R. Keith Campbell

   Current Opinion 26 December 2012 Pages: 2319 - 2325

3. US Food and Drug Administration’s Risk Evaluation and Mitigation Strategy for Extended-Release and Long-Acting Opioids

   • Sebastiano Mercadante
   • David Craig
   • Antonello Giarratano

   Current Opinion 26 December 2012 Pages: 2327 - 2332

4. Diagnosis and Therapeutic Management of Extra-Intestinal Manifestations of Inflammatory Bowel Disease

   • Guru Trikudanathan
   • Preethi G. K. Venkatesh
   • Udayakumar Navaneethan

   Review Article 26 December 2012 Pages: 2333 - 2349

5. Optimal Use of Treprostinil in Pulmonary Arterial Hypertension

   • Nika Skoro-Sajer

   Review Article 26 December 2012 Pages: 2351 - 2363

6. Primary Prevention of Major Cardiovascular and Cerebrovascular Events with Statins in Diabetic Patients

   • Folgerdiena M. de Vries
   • Petra Denig
   • Eelko Hak

   Systematic Review 26 December 2012 Pages: 2365 - 2373

7. Axitinib

   • Lily P. H. Yang
   • Kate McKeage

   Adis Drug Profile 26 December 2012 Pages: 2375 - 2384

8. Adalimumab

   • Celeste B. Burness
   • Emma D. Deeks

   Adis Drug Profile 26 December 2012 Pages: 2385 - 2395

9. Ingenol Mebutate Gel 0.015% and 0.05%

   • Gillian M. Keating

   Adis Drug Profile 26 December 2012 Pages: 2397 - 2405

10. Meningococcal Quadrivalent (Serogroups A, C, W135 and Y) Tetanus Toxoid Conjugate Vaccine (Nimenrix™)

    • Jamie D. Croxtall
    • Sohita Dhillon

    Adis Drug Evaluation 26 December 2012 Pages: 2407 - 2430

11. Boceprevir

    • Karly P. Garnock-Jones

    Adis Drug Evaluation 26 December 2012 Pages: 2431 - 2456